WebDisclosure WebDisclosure
Basculer en Français
11080 Companies
243095 Keywords
171240 Articles
130856 Press releases
Headlines Articles Press releases NanoViricides, Inc. Remove
  1. Home
  2. Companies
  3. NanoViricides, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 04/17/2023 at 12:45, 3 years 5 months ago

    NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate

    Logo of NanoViricides, Inc.
  • PRESS RELEASE

    published on 04/04/2023 at 13:45, 3 years 5 months ago

    NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidates

    Logo of NanoViricides, Inc.
  • PRESS RELEASE

    published on 02/15/2023 at 12:30, 3 years 7 months ago

    NanoViricides Has Filed its Quarterly Report - Company has Begun Production of Coronavirus Drug for Clinical Trials

    Logo of NanoViricides, Inc.
  • PRESS RELEASE

    published on 01/04/2023 at 12:35, 3 years 8 months ago

    NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT

    Logo of NanoViricides, Inc.
Previous page
1 ... 31 32
Accesswire
  • Published on 09/24/2026 at 17:45, 2 hours 22 minutes ago

    Jo-Jo Announces Resignation of Director

  • Published on 09/24/2026 at 14:55, 5 hours 12 minutes ago

    Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements

  • Published on 09/24/2026 at 14:30, 5 hours 37 minutes ago

    Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference

  • Published on 09/24/2026 at 14:00, 6 hours 7 minutes ago

    Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026

  • Published on 09/24/2026 at 14:00, 6 hours 7 minutes ago

    Reeflex Completes $1.23 Million Goes Order on Schedule Ahead of Vancouver Investor Conference

View all ACCESSWIRE
EQS Group
  • Published on 09/24/2026 at 19:00, 1 hour 7 minutes ago

    HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day

  • Published on 09/24/2026 at 18:40, 1 hour 26 minutes ago

    EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares

  • Published on 09/24/2026 at 18:15, 1 hour 52 minutes ago

    Epanko Value Engineering Identifies 20% Production Increase

  • Published on 09/24/2026 at 18:05, 2 hours 2 minutes ago

    DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026

  • Published on 09/24/2026 at 18:05, 2 hours 2 minutes ago

    EUHOMY CLOSES IFA 2026 WITH NINE HONORS ACROSS ITS ICE MAKER LINEUP

View all EQS
Les Echos
  • Published on 09/24/2026 at 18:31, 1 hour 36 minutes ago

    LNA SANTE : Mise à disposition du rapport financier semestriel 2026

  • Published on 09/24/2026 at 18:10, 1 hour 57 minutes ago

    Financial statements - 30 june 2026

  • Published on 09/24/2026 at 18:00, 2 hours 7 minutes ago

    GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026

  • Published on 09/24/2026 at 18:00, 2 hours 7 minutes ago

    GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026

  • Published on 09/24/2026 at 18:00, 2 hours 7 minutes ago

    i2S : Résultats 1er semestre 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy